share_log

AbbVie | SD: Specialized disclosure report

AbbVie | SD: Specialized disclosure report

艾伯維公司 | SD:專項披露公告
美股sec公告 ·  05/31 16:11
Moomoo AI 已提取核心訊息
AbbVie Inc., a biopharmaceutical company, has filed its Specialized Disclosure Report (Form SD) with the U.S. Securities and Exchange Commission (SEC) for the reporting period from January 1 to December 31, 2023. The report, which is required under Rule 13p-1 of the Securities Exchange Act, includes the company's Conflict Minerals Report as Exhibit 1.01. This report details AbbVie's due diligence regarding the source and chain of custody of conflict minerals used in their products. The Conflict Minerals Report is also available on AbbVie's investor relations website. The filing, signed by Scott T. Reents on May 31, 2024, does not apply to the Resource Extraction Issuer Disclosure, which is not applicable to the company.
AbbVie Inc., a biopharmaceutical company, has filed its Specialized Disclosure Report (Form SD) with the U.S. Securities and Exchange Commission (SEC) for the reporting period from January 1 to December 31, 2023. The report, which is required under Rule 13p-1 of the Securities Exchange Act, includes the company's Conflict Minerals Report as Exhibit 1.01. This report details AbbVie's due diligence regarding the source and chain of custody of conflict minerals used in their products. The Conflict Minerals Report is also available on AbbVie's investor relations website. The filing, signed by Scott T. Reents on May 31, 2024, does not apply to the Resource Extraction Issuer Disclosure, which is not applicable to the company.
生物製藥公司艾伯維公司已向美國證券交易委員會(SEC)提交了2023年1月1日至12月31日報告期的專業披露報告(SD表格)。根據《證券交易法》第13p-1條的規定,該報告將公司的衝突礦產報告列爲附錄1.01。本報告詳細介紹了艾伯維對其產品中使用的衝突礦產的來源和監管鏈的盡職調查。《衝突礦產報告》也可在艾伯維的投資者關係網站上查閱。該文件由斯科特·雷恩斯於2024年5月31日簽署,不適用於資源開採發行人披露聲明,該披露不適用於該公司。
生物製藥公司艾伯維公司已向美國證券交易委員會(SEC)提交了2023年1月1日至12月31日報告期的專業披露報告(SD表格)。根據《證券交易法》第13p-1條的規定,該報告將公司的衝突礦產報告列爲附錄1.01。本報告詳細介紹了艾伯維對其產品中使用的衝突礦產的來源和監管鏈的盡職調查。《衝突礦產報告》也可在艾伯維的投資者關係網站上查閱。該文件由斯科特·雷恩斯於2024年5月31日簽署,不適用於資源開採發行人披露聲明,該披露不適用於該公司。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息